Repligen (RGEN) Profit After Tax Growth (1y) (2011 - 2026)
Powered by 
Analysis
Repligen (RGEN) Profit After Tax Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 7.60% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 56.76% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 7.74% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -11.91% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | -3.15% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 7,105.94% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 16.87% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | -91.79% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -151.92% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -784.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -91.79% |
| Mar 31, 2026 | -20.80% |
| Dec 31, 2025 | 128.70% |
| Sep 30, 2025 | 62.64% |
| Jun 30, 2025 | 967.58% |
| Mar 31, 2025 | 219.24% |
| Dec 31, 2024 | -214.77% |
| Sep 30, 2024 | -45.83% |
| Jun 30, 2024 | -71.13% |
| Mar 31, 2024 | -82.01% |
| Dec 31, 2023 | -133.76% |
| Sep 30, 2023 | -58.12% |
| Jun 30, 2023 | -60.32% |
| Mar 31, 2023 | -60.98% |
| Dec 31, 2022 | 67.40% |
| Sep 30, 2022 | 20.62% |
| Jun 30, 2022 | 26.69% |
| Mar 31, 2022 | 59.47% |
| Dec 31, 2021 | 47.78% |
| Sep 30, 2021 | 130.20% |